|
GS185131: GO:0044699 single-organism process
|
|
GS176836: HP:0000422 Abnormality of the nasal bridge
|
|
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
|
|
GS177033: HP:0000437 Depressed nasal tip
|
|
GS136014: heart failure modifier 1 (Hrtfm1, Published QTL Chr 2)
|
|
GS176826: HP:0000202 Oral cleft
|
|
GS174646: HP:0000951 Abnormality of the skin
|
|
GS164220: MP:0002882 abnormal neuron morphology
|
|
GS171320: HP:0100360 Contractures of the joints of the upper limbs
|
|
GS198685: GO:0048522 positive regulation of cellular process
|
|
GS135594: mean cell hemoglobin concentration QTL 1 (Chcmq1, Published QTL Chr 2)
|
|
GS166120: MP:0002106 abnormal muscle physiology
|
|
GS201949: GO:0044699 single-organism process
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS176703: HP:0009028 Generalized weakness of limb muscles
|
|
GS188641: GO:0071944 cell periphery
|
|
GS189244: GO:0097285 cell-type specific apoptotic process
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS175107: HP:0003808 Abnormal muscle tone
|
|
GS175900: HP:0009118 Aplasia/Hypoplasia of the mandible
|
|
GS136114: body length 1 (Lgth1, Published QTL Chr 2)
|
|
GS170848: HP:0006266 Small placenta
|
|
GS173204: HP:0002389 Cavum septum pellucidum
|
|
GS178461: GO:0009987 cellular process
|
|
GS173946: HP:0002438 Cerebellar malformation
|
|
GS175007: HP:0003391 Gower sign
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS135524: body weight QTL 8 (Bwtq8, Published QTL Chr 2)
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS192041: GO:0043169 cation binding
|
|
GS172261: HP:0000357 Abnormal location of ears
|
|
GS174002: HP:0000189 Narrow palate
|
|
GS174612: HP:0001600 Abnormality of the larynx
|
|
GS207578: GO:0007271 synaptic transmission, cholinergic
|
|
GS172294: HP:0001510 Growth delay
|
|
GS190881: GO:0035255 ionotropic glutamate receptor binding
|
|
GS129192: type 2 diabetes mellitus 2 in SMXA RI mice (T2dm2sa Published QTL Chr 2)
|
|
GS174134: HP:0002012 Abnormality of the abdominal organs
|
|
GS129157: modifier of hg 1 (Mohg1 Published QTL Chr 2)
|
|
GS175103: HP:0000288 Abnormality of the philtrum
|
|
GS179984: GO:0043523 regulation of neuron apoptotic process
|
|
GS193268: GO:0005575 cellular_component
|
|
GS173786: HP:0003457 EMG abnormality
|
|
GS170614: MP:0001055 failure of neuromuscular synapse postsynaptic differentiation
|
|
GS171164: HP:0004887 Respiratory failure requiring assisted ventilation
|
|
GS182241: GO:0043068 positive regulation of programmed cell death
|
|
GS171596: HP:0000164 Abnormality of the teeth
|
|
GS195083: GO:0007267 cell-cell signaling
|
|
GS175354: HP:0003473 Fatigable weakness
|
|
GS170968: HP:0000156 High-arched palate
|
|
GS172701: HP:0002650 Scoliosis
|
|
GS176718: HP:0000078 Abnormality of the genital system
|
|
GS175411: HP:0100871 Abnormality of the palm
|
|
GS175893: HP:0000932 Abnormality of the posterior cranial fossa
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS135739: dextran sodium sulfate induced colitis QTL2 (Dssc2, Published QTL Chr 2)
|
|
GS175048: HP:0006824 Cranial nerve paralysis
|
|
GS176107: HP:0000929 Abnormality of the skull
|
|
GS172293: HP:0001511 Intrauterine growth retardation
|
|
GS172032: HP:0000366 Abnormality of the nose
|
|
GS173995: HP:0000508 Ptosis
|
|
GS196883: GO:0097060 synaptic membrane
|
|
GS173372: HP:0011297 Abnormality of the digits
|
|
GS170610: MP:0001051 abnormal somatic motor system morphology
|
|
GS35969: Neocortex Gene expression correlates of Handling induced convulsion score in Males BXD
|
|
GS175332: HP:0000032 Abnormality of male external genitalia
|
|
GS172273: HP:0001196 Short umbilical cord
|
|
GS165466: MP:0003632 abnormal nervous system morphology
|
|
GS178334: GO:0007267 cell-cell signaling
|
|
GS126646: Carbon Tetrachloride interacting genes (MeSH:D002251) in CTD
|
|
GS174412: HP:0007477 Abnormal dermatoglyphics
|
|
GS171893: HP:0011458 Abdominal symptom
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS175674: HP:0007360 Aplasia/Hypoplasia of the cerebellum
|
|
GS191106: GO:0044464 cell part
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS179517: GO:0012501 programmed cell death
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS208893: GO:0005856 cytoskeleton
|
|
GS201251: GO:0044424 intracellular part
|
|
GS127205: Tamoxifen interacting genes (MeSH:D013629) in CTD
|
|
GS171654: HP:0003121 Limb joint contracture
|
|
GS181893: GO:0048522 positive regulation of cellular process
|
|
GS196756: GO:0043523 regulation of neuron apoptotic process
|
|
GS165874: MP:0002133 abnormal respiratory system physiology
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS177440: GO:0006915 apoptotic process
|
|
GS136735: segregation of mitochondrial DNA QTL 2 (Smdq2, Published QTL Chr 2)
|
|
GS171126: HP:0000022 Abnormality of male internal genitalia
|
|
GS171453: HP:0003674 Onset
|
|
GS171806: HP:0005656 Positional foot deformities
|
|
GS205500: GO:0071944 cell periphery
|
|
GS171642: HP:0003700 Generalized amyotrophy
|
|
GS136200: lung tumor shape-determining 2 (Ltsd2, Published QTL Chr 2)
|
|
GS174292: HP:0011968 Feeding difficulties
|
|
GS174744: HP:0003398 Abnormality of the neuromuscular junction
|
|
GS135457: bone mineral density 3 (Bomd3, Published QTL Chr 2)
|
|
GS174066: HP:0100737 Abnormality of the hard palate
|
|
GS203688: GO:0008270 zinc ion binding
|
|
GS184509: GO:0045211 postsynaptic membrane
|
|
GS171277: HP:0100547 Abnormality of the forebrain
|
|
GS171997: HP:0001762 Talipes equinovarus
|
|
GS208228: GO:1901216 positive regulation of neuron death
|
|
GS174741: HP:0003394 Muscle cramps
|
|
GS178155: GO:0008219 cell death
|
|
GS173146: HP:0011282 Abnormality of the hindbrain
|
|
GS189374: GO:0042981 regulation of apoptotic process
|
|
GS176615: HP:0000277 Abnormality of the mandible
|
|
GS174073: HP:0009127 Abnormality of the musculature of the limbs
|
|
GS173137: HP:0011821 Abnormality of facial skeleton
|
|
GS208978: GO:0043169 cation binding
|
|
GS175601: HP:0002086 Abnormality of the respiratory system
|
|
GS176437: HP:0002334 Abnormality of the cerebellar vermis
|
|
GS171999: HP:0001760 Abnormality of the foot
|
|
GS136377: obesity QTL 3 (Obq3, Published QTL Chr 2)
|
|
GS170927: HP:0001283 Bulbar palsy
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS136872: T cell ratio modifier QTL 2 (Trmq2, Published QTL Chr 2)
|
|
GS172185: HP:0002977 Aplasia/Hypoplasia involving the central nervous system
|
|
GS171643: HP:0003701 Proximal muscle weakness
|
|
GS171944: HP:0003324 Generalized muscle weakness
|
|
GS172854: HP:0004302 Functional motor problems.
|
|
GS172853: HP:0004303 Abnormality of muscle fibers
|
|
GS173882: HP:0001305 Dandy-Walker malformation
|
|
GS171226: HP:0000812 Abnormal internal genitalia
|
|
GS178426: GO:0005102 receptor binding
|
|
GS136344: nitrous oxide antinociception 1 (Noan1, Published QTL Chr 2)
|
|
GS176804: HP:0001850 Abnormality of the tarsal bones
|
|
GS206237: GO:0042981 regulation of apoptotic process
|
|
GS177034: HP:0000436 Abnormality of the nasal tip
|
|
GS174879: HP:0002104 Apnea
|
|
GS172360: HP:0004323 Abnormality of body weight
|
|
GS172604: HP:0005445 Widened posterior fossa
|
|
GS173697: HP:0001319 Neonatal hypotonia
|
|
GS184883: GO:0010942 positive regulation of cell death
|
|
GS194172: GO:0006915 apoptotic process
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS189484: GO:0023052 signaling
|
|
GS201696: GO:0010941 regulation of cell death
|
|
GS135299: alcohol preference QTL 2 (Alpq2, Published QTL Chr 2)
|
|
GS176639: HP:0011356 Regional abnormality of skin
|
|
GS136090: lean body mass 2 (Lbm2, Published QTL Chr 2)
|
|
GS175390: HP:0011007 Age of onset
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS174331: HP:0002715 Abnormality of the immune system
|
|
GS172582: HP:0001838 Vertical talus
|
|
GS186744: GO:0043226 organelle
|
|
GS197471: GO:0044456 synapse part
|
|
GS209960: GO:0003008 system process
|
|
GS202715: GO:0035637 multicellular organismal signaling
|
|
GS182835: GO:0005622 intracellular
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS176830: HP:0011514 Abnormality of binocular vision
|
|
GS174418: HP:0010950 Abnormality of the fourth ventricle
|
|
GS186836: GO:0008270 zinc ion binding
|
|
GS171178: HP:0000238 Hydrocephalus
|
|
GS171253: HP:0002817 Abnormality of the upper limb
|
|
GS166244: MP:0002752 abnormal somatic nervous system morphology
|
|
GS173673: HP:0100295 Muscle fiber atrophy
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS206111: GO:0097285 cell-type specific apoptotic process
|
|
GS171424: HP:0002814 Abnormality of the lower limb
|
|
GS176231: HP:0010938 Abnormality of the external nose
|
|
GS173427: HP:0003680 Nonprogressive disorder
|
|
GS84131: ethanol consumption (Published QTL, Chr 2)
|
|
GS171904: HP:0003826 Stillbirth
|
|
GS174326: HP:0003199 Decreased muscle mass
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS174481: HP:0010576 Intracranial cystic lesion
|
|
GS166450: MP:0011089 complete perinatal lethality
|
|
GS189860: GO:0043167 ion binding
|
|
GS174533: HP:0003388 Easy fatigability
|
|
GS167656: MP:0001943 abnormal respiration
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS136129: lithogenic gene 1 (Lith1, Published QTL Chr 2)
|
|
GS172839: HP:0010674 Abnormality of the curvature of the vertebral column
|
|
GS176610: HP:0003593 Infantile onset
|
|
GS196633: GO:0070997 neuron death
|
|
GS174940: HP:0100767 Abnormality of the placenta
|
|
GS172034: HP:0000368 Low-set, posteriorly rotated ears
|
|
GS173111: HP:0010488 Aplasia/Hypoplasia of the palmar creases
|
|
GS172272: HP:0001197 Abnormality of prenatal development or birth
|
|
GS175020: HP:0001622 Premature birth
|
|
GS180672: GO:0044456 synapse part
|
|
GS187747: GO:0019226 transmission of nerve impulse
|
|
GS191310: GO:1901214 regulation of neuron death
|
|
GS172993: HP:0001321 Cerebellar hypoplasia
|
|
GS176806: HP:0003812 Phenotypic variability
|
|
GS136717: susceptibility to lung cancer 2 (Sluc2, Published QTL Chr 2)
|
|
GS171855: HP:0000597 Ophthalmoparesis
|
|
GS180108: GO:0097060 synaptic membrane
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS172271: HP:0001194 Abnormalities of placenta and umbilical cord
|
|
GS172572: HP:0000347 Micrognathia
|
|
GS172928: HP:0011729 Abnormality of joint mobility
|
|
GS206742: GO:0043167 ion binding
|
|
GS173065: HP:0003679 Pace of progression
|
|
GS135825: ethanol response acute (Etohr, Published QTL Chr 2)
|
|
GS184267: GO:0005794 Golgi apparatus
|
|
GS173079: HP:0000496 Abnormality of eye movement
|
|
GS171121: HP:0001059 Pterygia
|
|
GS175883: HP:0007375 Abnormality of the septum pellucidum
|
|
GS171124: HP:0010881 Abnormality of the umbilical cord
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS189865: GO:0033130 acetylcholine receptor binding
|
|
GS171100: HP:0000759 Abnormality of the peripheral nervous system
|
|
GS197115: GO:0043525 positive regulation of neuron apoptotic process
|
|
GS171251: HP:0003549 Abnormality of connective tissue
|
|
GS195082: GO:0007268 synaptic transmission
|
|
GS174076: HP:0009122 Aplasia/Hypoplasia affecting bones of the axial skeleton
|
|
GS172906: HP:0003319 Abnormality of the cervical spine
|
|
GS177009: HP:0003403 EMG: decremental response of compound muscle action potential (CMAP) to repetitive nerve stimulation
|
|
GS199779: GO:0043065 positive regulation of apoptotic process
|
|
GS128575: Ethanol induced LORR Chr# 2
|
|
GS173512: HP:0000306 Abnormality of the chin
|
|
GS84130: ethanol response acute (Published QTL, Chr 2)
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS175268: HP:0001167 Abnormality of finger
|
|
GS190882: GO:0035254 glutamate receptor binding
|
|
GS199039: GO:0043068 positive regulation of programmed cell death
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS172989: HP:0001324 Muscle weakness
|
|
GS171587: HP:0001561 Polyhydramnios
|
|
GS171936: HP:0000883 Thin ribs
|
|
GS181473: GO:0005488 binding
|
|
GS129195: Tmc1 modifier 1 (Tmc1m1 Published QTL Chr 2)
|
|
GS172096: HP:0000581 Blepharophimosis
|
|
GS173110: HP:0010489 Absence of the palmar creases
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS175823: HP:0002093 Respiratory insufficiency
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS196930: GO:0065007 biological regulation
|
|
GS171144: HP:0005280 Depressed nasal bridge
|
|
GS190714: GO:0016020 membrane
|
|
GS176477: HP:0002118 Abnormality of the cerebral ventricles
|
|
GS174455: HP:0004347 Weakness of muscles of respiration
|
|
GS171627: HP:0000470 Short neck
|
|
GS175098: HP:0000284 Abnormality of the ocular region
|
|
GS207616: GO:0016020 membrane
|
|
GS173787: HP:0002813 Abnormality of limb bone morphology
|
|
GS182981: GO:0043067 regulation of programmed cell death
|
|
GS171616: HP:0100490 Camptodactyly of finger
|
|
GS171647: HP:0011844 Abnormal appendicular skeleton morphology
|
|
GS175979: HP:0009115 Aplasia/Hypoplasia involving the skeleton
|
|
GS195214: GO:0009987 cellular process
|
|
GS129156: multigenic obesity QTL 5 (Mobq5 Published QTL Chr 2)
|
|
GS173288: HP:0000316 Hypertelorism
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS171197: HP:0001945 Fever
|
|
GS176586: HP:0001270 Motor delay
|
|
GS185880: GO:0035637 multicellular organismal signaling
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS175673: HP:0100022 Abnormality of movement
|
|
GS176170: HP:0001252 Muscular hypotonia
|
|
GS26122: Positional candidate genes for Mechanical Nociception - Tail Clip Test [Pain] in Males for Suggestive BXD QTL on Chr2 from 80 to 100 Mb
|
|
GS172562: HP:0003070 Elbow ankylosis
|
|
GS178333: GO:0007268 synaptic transmission
|
|
GS174917: HP:0000765 Abnormality of the thorax
|
|
GS166798: MP:0001954 respiratory distress
|
|
GS174388: HP:0002089 Pulmonary hypoplasia
|
|
GS176029: HP:0009116 Aplasia/Hypoplasia involving bones of the skull
|
|
GS177000: HP:0001291 Abnormality of the cranial nerves
|
|
GS171607: HP:0011337 Abnormality of mouth size
|
|
GS208156: GO:0031594 neuromuscular junction
|
|
GS174899: HP:0100886 Abnormality of globe location
|
|
GS172268: HP:0001193 Ulnar deviation of the hand or of fingers of the hand
|
|
GS176695: HP:0009811 Abnormality of the elbow
|
|
GS179748: GO:0030054 cell junction
|
|
GS173516: HP:0000301 Abnormality of facial musculature
|
|
GS198263: GO:0005488 binding
|
|
GS172433: HP:0002644 Abnormality of pelvic girdle bone morphology
|
|
GS184884: GO:0010941 regulation of cell death
|
|
GS191239: GO:0031594 neuromuscular junction
|
|
GS206355: GO:0023052 signaling
|
|
GS174145: HP:0005918 Abnormality of phalanx of finger
|
|
GS175169: HP:0001317 Abnormality of the cerebellum
|
|
GS186067: GO:0050877 neurological system process
|
|
GS125669: Phenylephrine interacting genes (MeSH:D010656) in CTD
|
|
GS171703: HP:0003443 Decreased size of nerve terminals
|
|
GS175529: HP:0000001 All
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS175423: HP:0010461 Abnormality of the male genitalia
|
|
GS174135: HP:0002015 Dysphagia
|
|
GS176803: HP:0001260 Dysarthria
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS193018: GO:0003008 system process
|
|
GS199781: GO:0043067 regulation of programmed cell death
|
|
GS172661: HP:0003100 Slender long bone
|
|
GS171634: HP:0008050 Abnormality of the palpebral fissures
|
|
GS195977: GO:0007154 cell communication
|
|
GS173970: HP:0009473 Joint contracture of the hand
|
|
GS188813: GO:0045202 synapse
|
|
GS175459: HP:0009484 Deviation of the hand or of fingers of the hand
|
|
GS165243: MP:0010770 preweaning lethality
|
|
GS173287: HP:0000315 Abnormality of the orbital region
|
|
GS184447: GO:0044424 intracellular part
|
|
GS176258: HP:0004370 Abnormality of temperature regulation
|
|
GS129169: plasma plant sterol 2b (Plast2b Published QTL Chr 2)
|
|
GS194905: GO:0008219 cell death
|
|
GS171394: HP:0000174 Abnormality of the palate
|
|
GS172362: HP:0004325 Decreased body weight
|
|
GS171593: HP:0000160 Narrow mouth
|
|
GS179864: GO:0070997 neuron death
|
|
GS173601: HP:0010827 Abnormality of the seventh cranial nerve
|
|
GS174230: HP:0000303 Mandibular prognathia
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS205674: GO:0045202 synapse
|
|
GS174453: HP:0001438 Abnormality of the abdomen
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS173367: HP:0005257 Thoracic hypoplasia
|
|
GS180164: GO:0008150 biological_process
|
|
GS174858: HP:0200007 Abnormal size of the palpebral fissures
|
|
GS175333: HP:0000035 Abnormality of the testis
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS175191: HP:0002060 Abnormality of the cerebrum
|
|
GS172622: HP:0000651 Diplopia
|
|
GS170608: MP:0001053 abnormal neuromuscular synapse morphology
|
|
GS172288: HP:0000358 Posteriorly rotated ears
|
|
GS172670: HP:0002363 Abnormality of the brainstem
|
|
GS171833: HP:0000119 Abnormality of the genitourinary system
|
|
GS174833: HP:0006817 Aplasia/Hypoplasia of the cerebellar vermis
|
|
GS176756: HP:0011420 Death
|
|
GS176568: HP:0000486 Strabismus
|
|
GS171448: HP:0000606 Abnormality of the periorbital region
|
|
GS174400: HP:0001612 Weak cry
|
|
GS172246: HP:0001371 Flexion contracture
|
|
GS208012: GO:0044464 cell part
|
|
GS172260: HP:0000356 Abnormality of the outer ear
|
|
GS210212: GO:0005575 cellular_component
|
|
GS136030: induction of brown adipocytes 1 (Iba1, Published QTL Chr 2)
|
|
GS175994: HP:0000464 Abnormality of the neck
|
|
GS195176: GO:0005102 receptor binding
|
|
GS87019: Table S5: List of Cocaine-Treated WT vs. Saline-Treated WT Significantly Regulated Genes. [DRG]
provisional
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS135235: activity response to ethanol 2 (Actre2, Published QTL Chr 2)
|
|
GS176885: HP:0002693 Abnormality of the skull base
|
|
GS170853: HP:0006261 Abnormality of phalangeal joints of the hand
|
|
GS175577: HP:0003202 Amyotrophy
|
|
GS182979: GO:0043065 positive regulation of apoptotic process
|
|
GS190679: GO:0007271 synaptic transmission, cholinergic
|
|
GS136914: vertebral morphology and mechanical traits 2 (Vmmt2, Published QTL Chr 2)
|
|
GS171810: HP:0005651 Flexion contracture of finger
|
|
GS135481: bone response to mechanical loading 14 (Brml14, Published QTL Chr 2)
|
|
GS164491: MP:0009538 abnormal synapse morphology
|
|
GS164261: MP:0002081 perinatal lethality
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS171863: HP:0008365 Abnormality of the talus
|
|
GS201313: GO:0045211 postsynaptic membrane
|
|
GS173507: HP:0000520 Proptosis
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS135454: bone length and organs QTL 1 (Bodq1, Published QTL Chr 2)
|
|
GS172033: HP:0000369 Low-set ears
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS176801: HP:0001263 Global developmental delay
|
|
GS172195: HP:0000504 Abnormality of vision
|
|
GS174385: HP:0002088 Abnormality of the lung
|
|
GS166813: MP:0001951 abnormal breathing pattern
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS84132: ethanol induced locomotor activity (Published QTL, Chr 2)
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS203755: GO:0016265 death
|
|
GS174721: HP:0000772 Abnormality of the ribs
|
|
GS136442: peak bone mineral density 2 (Pbmd2, Published QTL Chr 2)
|
|
GS196511: GO:0030054 cell junction
|
|
GS179153: GO:0051402 neuron apoptotic process
|
|
GS201695: GO:0010942 positive regulation of cell death
|
|
GS165789: MP:0005369 muscle phenotype
|
|
GS172387: HP:0002804 Arthrogryposis multiplex congenita
|
|
GS176478: HP:0002119 Ventriculomegaly
|
|
GS177025: HP:0010628 Facial palsy
|
|
GS191309: GO:1901216 positive regulation of neuron death
|
|
GS182834: GO:0005623 cell
|
|
GS175458: HP:0003554 Type 2 muscle fiber atrophy
|
|
GS177051: HP:0001155 Abnormality of the hand
|
|
GS173083: HP:0000492 Abnormality of the eyelid
|
|
GS171919: HP:0002198 Dilated fourth ventricle
|
|
GS172379: HP:0002803 Congenital contractures
|
|
GS174914: HP:0003011 Abnormality of the musculature
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS173618: HP:0002747 Respiratory insufficiency due to muscle weakness
|
|
GS136793: taste-saccharin preference 1 (Taste1, Published QTL Chr 2)
|
|
GS168012: MP:0010832 lethality during fetal growth through weaning
|
|
GS171586: HP:0001560 Abnormality of the amniotic fluid
|
|
GS172569: HP:0000343 Long philtrum
|
|
GS175125: HP:0000028 Cryptorchidism
|
|
GS171381: HP:0001558 Decreased fetal movement
|
|
GS176038: HP:0002795 Functional respiratory abnormality
|
|
GS176066: HP:0002350 Cerebellar cyst
|
|
GS180333: GO:0043525 positive regulation of neuron apoptotic process
|
|
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
|
|
GS187146: GO:0044700 single organism signaling
|
|
GS171543: HP:0000276 Long face
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS171388: HP:0001557 Prenatal movement abnormality
|
|
GS199634: GO:0005623 cell
|
|
GS208229: GO:1901214 regulation of neuron death
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS171640: HP:0000476 Cystic hygroma
|
|
GS176694: HP:0009810 Abnormality of the joints of the upper limbs
|
|
GS197009: GO:0005886 plasma membrane
|
|
GS175814: HP:0011024 Abnormality of the gastrointestinal tract
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS173563: HP:0000692 Misalignment of teeth
|
|
GS196282: GO:0012501 programmed cell death
|
|
GS201431: GO:0005515 protein binding
|
|
GS173743: HP:0001999 Abnormal facial shape
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS173147: HP:0011283 Abnormality of the metencephalon
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS174101: HP:0001018 Abnormal palmar dermatoglyphics
|
|
GS172992: HP:0001320 Cerebellar vermis hypoplasia
|
|
GS170825: HP:0002167 Neurological speech impairment
|
|
GS171910: HP:0003828 Variable expressivity
|
|
GS191954: GO:0005856 cytoskeleton
|
|
GS164339: MP:0002327 abnormal respiratory function
|
|
GS174579: HP:0002031 Abnormality of the esophagus
|
|
GS195919: GO:0051402 neuron apoptotic process
|
|
GS172298: HP:0001518 Small for gestational age
|
|
GS175117: HP:0001883 Talipes
|
|
GS87065: Table S4: List of Saline-Treated HDAC5 KO vs. Saline-Treated WT Significantly Regulated Genes. [DRG]
provisional
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS135418: bitterness sensitivity 1 (Bits1, Published QTL Chr 2)
|
|
GS135708: diabetes susceptibility QTL 5 (Dbsq5, Published QTL Chr 2)
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS135554: CD8 memory T cell subset 3 (Cd8mts3, Published QTL Chr 2)
|
|
GS172253: HP:0001376 Limitation of joint mobility
|
|
GS175981: HP:0000163 Abnormality of the oral cavity
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS186899: GO:0016265 death
|
|
GS176100: HP:0000925 Abnormality of the vertebral column
|
|
GS204608: GO:0019226 transmission of nerve impulse
|
|
GS174606: HP:0001608 Abnormality of the voice
|
|
GS171848: HP:0000598 Abnormality of the ear
|
|
GS171395: HP:0000175 Cleft palate
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS213073: Genes with suggestive difference in (PB6F1) vs (B6PF1 + B6 + PWD) comparison
|
|
GS184629: GO:0005515 protein binding
|
|
GS172871: HP:0010490 Abnormality of the palmar creases
|
|
GS173993: HP:0000506 Telecanthus
|
|
GS209291: GO:0046914 transition metal ion binding
|
|
GS176900: HP:0000218 High palate
|
|
GS169489: MP:0000747 muscle weakness
|
|
GS179211: GO:0007154 cell communication
|
|
GS206747: GO:0033130 acetylcholine receptor binding
|
|
GS173244: HP:0001331 Absent septum pellucidum
|
|
GS180152: GO:0065007 biological regulation
|
|
GS136022: hyperoxia susceptibility locus 1 (Hsl1, Published QTL Chr 2)
|
|
GS136950: weight gain in high growth mice 5 (Wg5, Published QTL Chr 2)
|
|
GS174102: HP:0011799 Abnormality of facial soft tissue
|
|
GS174450: HP:0006703 Aplasia/Hypoplasia of the lungs
|
|
GS192354: GO:0046914 transition metal ion binding
|
|
GS173337: HP:0000689 Dental malocclusion
|
|
GS135824: ethanol induced locomotor activity (Etohila, Published QTL Chr 2)
|
|
GS202899: GO:0050877 neurological system process
|
|
GS169836: MP:0005388 respiratory system phenotype
|
|
GS84129: activity response to ethanol (Published QTL, Chr 2)
|
|
GS175602: HP:0002087 Abnormality of the upper respiratory tract
|
|
GS201075: GO:0005794 Golgi apparatus
|
|
GS172021: HP:0001367 Abnormal joint morphology
|
|
GS173024: HP:0000811 Abnormal external genitalia
|
|
GS170965: HP:0000153 Abnormality of the mouth
|
|
GS171204: HP:0011314 Abnormality of long bone morphology
|
|
GS203594: GO:0043226 organelle
|
|
GS172667: HP:0011805 Abnormality of muscle morphology
|